Age-related macular degeneration (AMD) is a well-characterised disease responsible for being the principal cause of visual impairment in elderly patients (1). Generally, it is subdivided into two categories: ‘dry’ and ‘wet’. Dry AMD is more common than wet AMD, accounting for more than 85% of AMD cases (2). However, the severity of wet AMD is such that it is responsible for 80% of cases with severe visual impairment (2).